Gryphon Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $788K | Sell |
1,942
-30
| -2% | -$12.2K | 0.1% | 132 |
|
|
2025
Q1 | $981K | Buy |
1,972
+271
| +16% | +$135K | 0.14% | 98 |
|
|
2024
Q4 | $885K | Sell |
1,701
-35
| -2% | -$18.2K | 0.13% | 96 |
|
|
2024
Q3 | $1.07M | Buy |
1,736
+162
| +10% | +$100K | 0.15% | 88 |
|
|
2024
Q2 | $871K | Buy |
1,574
+163
| +12% | +$90.2K | 0.13% | 97 |
|
|
2024
Q1 | $820K | Sell |
1,411
-73
| -5% | -$42.4K | 0.14% | 100 |
|
|
2023
Q4 | $794K | Buy |
1,484
+116
| +8% | +$62K | 0.14% | 104 |
|
|
2023
Q3 | $693K | Sell |
1,368
-5
| -0.4% | -$2.53K | 0.16% | 69 |
|
|
2023
Q2 | $716K | Sell |
1,373
-52
| -4% | -$27.1K | 0.16% | 71 |
|
|
2023
Q1 | $821K | Sell |
1,425
-23
| -2% | -$13.3K | 0.19% | 61 |
|
|
2022
Q4 | $797K | Sell |
1,448
-1
| -0.1% | -$551 | 0.19% | 66 |
|
|
2022
Q3 | $735K | Buy |
1,449
+86
| +6% | +$43.6K | 0.19% | 62 |
|
|
2022
Q2 | $740K | Buy |
1,363
+7
| +0.5% | +$3.8K | 0.18% | 60 |
|
|
2022
Q1 | $801K | Sell |
1,356
-11
| -0.8% | -$6.5K | 0.16% | 70 |
|
|
2021
Q4 | $912K | Buy |
1,367
+77
| +6% | +$51.4K | 0.17% | 68 |
|
|
2021
Q3 | $737K | Buy |
1,290
+56
| +5% | +$32K | 0.16% | 78 |
|
|
2021
Q2 | $616K | Buy |
1,234
+53
| +4% | +$26.5K | 0.14% | 71 |
|
|
2021
Q1 | $538K | Buy |
1,181
+24
| +2% | +$10.9K | 0.12% | 86 |
|
|
2020
Q4 | $538K | Buy |
1,157
+2
| +0.2% | +$930 | 0.14% | 82 |
|
|
2020
Q3 | $510K | Buy |
1,155
+123
| +12% | +$54.3K | 0.15% | 72 |
|
|
2020
Q2 | $373K | Sell |
1,032
-99
| -9% | -$35.8K | 0.12% | 92 |
|
|
2020
Q1 | $320K | Buy |
1,131
+140
| +14% | +$39.6K | 0.12% | 94 |
|
|
2019
Q4 | $322K | Buy |
+991
| New | +$322K | 0.08% | 131 |
|
|
2018
Q3 | – | Sell |
-214
| Closed | -$45K | – | 765 |
|
|
2018
Q2 | $45K | Buy |
214
+6
| +3% | +$1.26K | 0.02% | 244 |
|
|
2018
Q1 | $42K | Buy |
208
+1
| +0.5% | +$202 | 0.02% | 254 |
|
|
2017
Q4 | $40K | Buy |
+207
| New | +$40K | 0.02% | 287 |
|